Log in

CVE:IANiAnthus Capital Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive IAN News and Ratings via Email

Sign-up to receive the latest news and ratings for IAN and its competitors with MarketBeat's FREE daily newsletter.

iAnthus Capital (CVE:IAN) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of iAnthus Capital?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iAnthus Capital in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for iAnthus Capital.

When is iAnthus Capital's next earnings date?

iAnthus Capital is scheduled to release its next quarterly earnings announcement on Thursday, June 4th 2020. View our earnings forecast for iAnthus Capital.

Has iAnthus Capital been receiving favorable news coverage?

Press coverage about IAN stock has trended very negative on Sunday, InfoTrie reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. iAnthus Capital earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news aboutiAnthus Capital.

What other stocks do shareholders of iAnthus Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iAnthus Capital investors own include Aphria (APHA), Emerald Health Therapeutics (EMH), OrganiGram (OGI), Hexo (HEXO), Netflix (NFLX), Canopy Growth (WEED), Aurora Cannabis (ACB), Albemarle (ALB), CVS Health (CVS) and Supreme Cannabis (FIRE).

What is iAnthus Capital's stock symbol?

iAnthus Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IAN."

How do I buy shares of iAnthus Capital?

Shares of IAN and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.